How medical affairs can turn patient voice into measurable impact
Integrating the patient voice into decision-making has become a strategic priority across pharma, yet it often remains more of an ambition than an operating model. Over the years, medical affairs has progressively evolved its approach from understanding patient realities to embedding patient perspectives into organizational capabilities—and ultimately demonstrating measurable impact.
Figure: The evolution of the patient voice in medical affairs
Our new white paper draws on ZS’s voice of patients study of 100 breast cancer patients in the U.S. and examines why provider and patient perspectives must both be valued. It also shows how patient insights can reveal barriers that clinical measures alone often miss, from emotional support and care navigation to treatment initiation, adherence and access.
Is your organization seeking to improve evidence relevance, strengthen stakeholder engagement and connect scientific exchange to better patient outcomes? This white paper offers a practical view of how medical affairs can help pharma turn the patient’s voice into action.
